Evidence map›Paper›PMID 34311265›Full record

ReviewCurrent opinion in microbiology2021

Balancing de novo synthesis and salvage of lipids by Leishmania amastigotes.

Kai Zhang

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular Characterization of Sterol C4-Methyl Oxidase inInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Non-Vesicular Lipid Transport Machinery inInternational journal of molecular sciences · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Fatty Acid Profiles ofPathogens (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kai ZhangDepartment of Biological Sciences, Texas Tech University, Lubbock, TX 79409, USA. Electronic address: kai.zhang@ttu.edu.
Texas Tech University · US

Funding

Identification of CYP5122A1 inhibitors as chemical probes for Leishmania biologyR01AI139198 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI WANG, ZHUO MICHAEL · 2019 to 2022
$2.1M
Exploring an Essential and Dangerous Pathway in Leishmania ParasitesR01AI099380 · NIAID · TEXAS TECH UNIVERSITY · PI ZHANG, KAI · 2013 to 2017
$1.8M
Phospholipid metabolism in LeishmaniaR15AI156746 · NIAID · TEXAS TECH UNIVERSITY · PI ZHANG, KAI · 2021 to 2024
$959k
NIAID NIH HHS R01 AI099380NIAID NIH HHS R01 AI139198NIAID NIH HHS R15 AI156746
6 · The paper itself

Abstract

Leishmania parasites replicate as flagellated, extracellular promastigotes in the sand fly vector and then differentiate into non-flagellated, intracellular amastigotes in the vertebrate host. Promastigotes rely on de novo synthesis to produce the majority of their lipids including glycerophospholipids, sterols and sphingolipids. In contrast, amastigotes acquire most of their lipids from the host although they retain some capacity for de novo synthesis. The switch from de novo synthesis to salvage reflects the transition of Leishmania from fast-replicating promastigotes to slow-growing, metabolically quiescent amastigotes. Future studies will reveal the uptake and remodeling of host lipids by amastigotes at the cellular and molecular levels. Blocking the lipid transfer from host to parasites may present a novel strategy to control Leishmania growth.

Indexed as

LeishmaniaLipidsSphingolipidsLipidsSphingolipids

Identifiers

PMID34311265
PMCPMC8463422
OpenAlexW3186643232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.